The Entorhinal Cortex and Aerobic Exercise in Aging (ECE)

May 8, 2023 updated by: Boston University
The overall goal of this study is to examine how regular exercise affects brain function, spatial memory, and virtual navigation. Participation in this research study will take approximately 4 months.

Study Overview

Detailed Description

The investigators are examining the effects of exercise and cardiovascular fitness on cognitive processes. Specifically, the investigators are examining if exercise improves brain function in a brain area known as the entorhinal cortex. Together with the hippocampus this brain area is important for memory formation and spatial navigation. Participation in this research study will take approximately 4 months. During this time, participants will make three initial study visits. The first visit is for informed consent and screening, the second visit is for baseline fitness testing, and the third visit is for cognitive testing and a functional MRI exam. Functional MRI is a brain imaging technique that uses a magnetic field to "take pictures" of the brain while a person performs a cognitive task. It will take up to approximately three weeks to complete these initial three study visits. Following the three initial study visits, the exercise-training program will begin. Participants will be randomized to one of two training programs: a cardiovascular endurance-training program (aerobic exercise) and a strength, balance, and flexibility training program (non-aerobic exercise). The exercise training program will last 12 weeks. There will be three one-hour exercise sessions per week. After completion of the exercise-training program, participants will attend two follow-up study visits. The first follow-up visit is for fitness testing. The second follow-up visit is for cognitive testing and an MRI exam.

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02118
        • Boston University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 60-80 years
  • Physical inactivity/sedentary status (The American College of Sports Medicine defines a sedentary lifestyle as a lifestyle in which a person is not participating in at least 30 minutes of moderate intensity physical activity on at least three days per week for at least three months.)
  • Generally healthy
  • Living in the greater Boston area
  • Fluent in English (must have attended elementary school and higher in English)
  • Non-smoking

Exclusion Criteria:

  • Poor vision that cannot be corrected with glasses or contact lenses
  • Presence of an acute infection
  • Diagnosis of kidney failure
  • Diagnosis of liver disease
  • Diagnosis of thyrotoxicosis/hyperthyroidism
  • Diagnosis of cancer
  • Diagnosis of severe anemia
  • Past or present conditions that affect cognitive functioning:

    • learning disability
    • neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)
    • psychiatric disorders or conditions within last 5 years (depression, anxiety disorder, etc.)
    • Severe stress
  • Evidence of cognitive impairment (e.g. dementia)
  • Claustrophobia (fear of small, enclosed spaces)
  • Obesity
  • Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and physical exercise:

    • heart conditions (e.g. heart attack, arrhythmias, etc.)
    • circulatory conditions (e.g. uncontrolled hypertension, leg claudication, high cholesterol, etc.)
    • respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)
    • current musculoskeletal impairments (e.g. fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)
    • diagnosis of electrolyte disorder or abnormality
    • presence of diabetes mellitus
  • Prescription medication or other drugs that treat heart, lung, or circulatory conditions (e.g. beta blockers, bronchodilators, etc.)
  • Prescription medication or other drugs that affect chemicals in the brain (e.g. antidepressants, anxiolytics, etc.)
  • Drug abuse or alcohol misuse
  • Metal in or on the body that cannot be removed (e.g. pacemaker, defibrillator, metal implant that is ferrous)
  • Some known abnormal MRI findings (case by case basis)
  • Regularly exercising
  • Unavailable for the approx. 4-month duration of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiovascular endurance
Participants will undergo cardiovascular endurance training. The trainer-supervised endurance training will involve walking on a treadmill at moderate intensity
Physical exercise at the Boston University Fitness and Recreation Center
Active Comparator: Strength, balance, and flexibility
Participants will undergo Strength, balance, and flexibility training.
Physical exercise at the Boston University Fitness and Recreation Center

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional MRI - Right Subiculum
Time Frame: 0 months-baseline (pre-intervention)

The fMRI is measuring blood oxygenation levels and blood flow in different regions of the brain and using that to determine activity changes in the brain. This measurement was obtained while participants were performing a virtual navigation task in the MRI scanner.

Data reported for fMRI is in beta-weight for navigation greater control contrast of BOLD images. The beta-weight is a standardized regression coefficient. Higher beta-weights mean greater activation and lower beta-weights mean less activation in specific brain regions being monitored. Negative beta-weights mean lower activation for the navigation condition than for the control condition, positive beta-weights mean greater activation for the navigation condition than for the control condition.

0 months-baseline (pre-intervention)
Structural MRI - Right Dentate Gyrus Head
Time Frame: 0 months-baseline (pre-intervention)
Measurement of regional brain volumes in the medial temporal lobes to assess change in regional brain volumes. Reported outcome measure is volume of the right anterior (i.e., head) dentate gyrus, a hippocampal subfield known to show plasticity in response to exercise in animal models. The hippocampus is part of the medial temporal lobes.
0 months-baseline (pre-intervention)
Cognitive Test Performance: Spatial Memory
Time Frame: 4 months
Participants will perform a spatial memory test during functional MRI. Measurements include baseline-to-follow-up change test performance.
4 months
Cognitive Test Performance: Virtual Navigation
Time Frame: 4 months
Participants will perform a virtual navigation test during functional MRI. Measurements include baseline-to-follow-up change in test performance.
4 months
Functional MRI - Post-intervention Right Subiculum
Time Frame: 4 months

The fMRI is measuring blood oxygenation levels and blood flow in different regions of the brain and using that to determine activity changes in the brain. This measurement was obtained while participants were performing a virtual navigation task in the MRI scanner.

Data reported for fMRI is in beta-weight for navigation greater control contrast of BOLD images. The beta-weight is a standardized regression coefficient. Higher beta-weights mean greater activation and lower beta-weights mean less activation in specific brain regions being monitored. Negative beta-weights mean lower activation for the navigation condition than for the control condition, positive beta-weights mean greater activation for the navigation condition than for the control condition.

4 months
Structural MRI - Post-intervention Right Dentate Gyrus Head
Time Frame: 4 months
Measurement of regional brain volumes in the medial temporal lobes to assess change in regional brain volumes. Reported outcome measure is volume of the right anterior (i.e., head) dentate gyrus, a hippocampal subfield known to show plasticity in response to exercise in animal models. The hippocampus is part of the medial temporal lobes.
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Aerobic Capacity
Time Frame: 4 months
Participants will perform a treadmill test to estimate baseline-to-follow-up change in aerobic capacity. Aerobic capacity is the maximum amount of oxygen (O2;(expressed in volume: VO2) a person can utilize during strenuous exercise. This maximum volume of oxygen is known as VO2max or aerobic capacity. For this study, we measured heart rate during the treadmill test and estimated VO2max from heart rate, thus we estimated VO2max rather than measured oxygen and carbondioxyde in the breath while exercising. VO2max is expressed in milliliters per kilogram of body weight per minute (ml/kg/min). We calculated percentage change from baseline to post-intervention.
4 months
Muscle Strength
Time Frame: 4 months
Participants will perform several muscle strength tests to estimate baseline-to-follow-up change in muscle strength. Percentage change in chess press weight lifted is reported in results.
4 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition measurement
Time Frame: 12 weeks
Measurement of lean body mass with bio-electrical impedance analysis (BIA) to estimate baseline-to-follow-up change in lean body mass.
12 weeks
Neuropsychological test score: spatial reasoning
Time Frame: 12 weeks
Participants will perform several neuropsychological tests of spatial reasoning to measure baseline-to-follow-up change in spatial reasoning ability. A composite score will be calculated.
12 weeks
Neuropsychological test score: spatial cognition
Time Frame: 12 weeks
Participants will perform several neuropsychological tests of spatial cognition to measure baseline-to-follow-up change in spatial cognition. A composite score will be calculated.
12 weeks
Neuropsychological test score: verbal memory
Time Frame: 12 weeks
Participants will perform a neuropsychological test of verbal memory to measure baseline-to-follow-up change in verbal memory.
12 weeks
Neuropsychological test score: visuospatial memory
Time Frame: 12 weeks
Participants will perform a neuropsychological test of visuospatial memory to measure baseline-to-follow-up change in memory.
12 weeks
Neuropsychological test score: executive function
Time Frame: 12 weeks
Participants will perform a neuropsychological test of executive function to measure baseline-to-follow-up change in executive function.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karin Schon, PhD, Boston University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2018

Primary Completion (Actual)

February 9, 2021

Study Completion (Actual)

February 9, 2021

Study Registration Dates

First Submitted

May 11, 2016

First Submitted That Met QC Criteria

May 15, 2016

First Posted (Estimate)

May 18, 2016

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 8, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Cardiovascular endurance

3
Subscribe